A drug that contains both THC (delta-9-tetrahydrocannabinol) and cannabidiol, CBD, is being studied. It is in a spray form for use in the mouth, either under the tongue, or inside the cheek. One trial, with a relatively small number of subjects showed that it was effective in treating neuropathic pain, sleep, allodynia, and disability.